This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Income
$5.6M
Filings
179
Unique Clients
14
Active Period
2002–2010
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Patent Reform (S. 515; H.R. 1260)
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Patent Reform (S. 515; H.R. 1260)
Client expense: — · Firm income: $40,000
Matched citations: S. 515
Patent Reform (S. 515; H.R. 1260)
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Patent Reform (S. 515; H.R. 1260)
Client expense: — · Firm income: $40,000
Matched citations: S. 515
Patent Reform (S. 515; H.R. 1260)
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Patent Reform (S. 515; H.R. 1260)
Client expense: — · Firm income: $40,000
Matched citations: S. 515
Patent Reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: AMGEN
Patent Reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1427
Patent Reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: S. 515
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: AMGEN
Patent Reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: S. 726
Patent reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · fourth_quarter · Client: AMGEN
Patent reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1427
Patent reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: S. 515
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · fourth_quarter · Client: AMGEN
Patent reform (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)-Promoting Innovation and Access to Life-Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: S. 726
Patent reform follow-on (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · third_quarter · Client: AMGEN
Patent reform follow-on (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1427
Patent reform follow-on (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)
Client expense: — · Firm income: $40,000
Matched citations: S. 515
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · third_quarter · Client: AMGEN
Patent reform follow-on (S. 515; H.R. 1260) BioSimilar legislation (S. 726; H.R. 1427)
Client expense: — · Firm income: $40,000
Matched citations: S. 726
Patent Reform legislation (S. 515; H.R. 1260) and USPTO policy matters.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Patent Reform legislation (S. 515; H.R. 1260) and USPTO policy matters.
Client expense: — · Firm income: $40,000
Matched citations: S. 515
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
2009 · second_quarter · Client: TOBACCO-FREE KIDS ACTION FUND
Smoking prevention and/or cessation. "The Family Smoking Prevention and Tobacco Control Act." (S. 625, H.R. 1256)
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1256
Family Smoking Prevention and Tobacco Control Act
2009 · second_quarter · Client: TOBACCO-FREE KIDS ACTION FUND
Smoking prevention and/or cessation. "The Family Smoking Prevention and Tobacco Control Act." (S. 625, H.R. 1256)
Client expense: — · Firm income: $10,000
Matched citations: S. 625
Patent Reform legislation (S. 515; H.R. 1260) and USPTO policy matters.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1260
Patent Reform legislation (S. 515; H.R. 1260) and USPTO policy matters.
Client expense: — · Firm income: $40,000
Matched citations: S. 515
Green Jobs Act of 2007
2009 · second_quarter · Client: BOYS & GIRLS CLUBS OF AMERICA
Juvenile Justice grants, " BGCA grant re-authorization proposal; and appropriation. (H.R. 2847)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2847
Source: Senate LDA